Dr. Kelsey Moody, CEO at Ichor, speaks on a panel at the 2019 NIA Geroscience Summit

Ichor’s CEO Participates in NIA Geroscience Summit

Posted Leave a commentPosted in Auctus Biologics, Ichor

4 – 5 November 2019 Bethesda, MD: The third annual Geroscience Summit was organized by the Trans-NIH Geroscience Interest Group (GSIG). The Geroscience Summit is hosted by the National Institute of Health, and brings together interdisciplinary experts in the field of age-related diseases to bring their expertise to the field of geroscience. Geroscience seeks interdisciplinary […]

Scientist at Ichor in LaFayette, NY

Ichor’s Auctus Biologics Closes Quick $1.5MM

Posted Posted in Auctus Biologics, Ichor

Auctus Biologcs, Inc., a new portfolio company of Ichor Therapeutics, Inc., announced today the closure of $1.5MM in seed funding. The company will develop RPtag, a hyper-stable antibody mimetic scaffold published earlier this year in the peer-reviewed journal ACS Biochemistry, to take on conventional clinical antibody therapy as an orally bioavailable formulation. New high priority immunosenescence and gastrointestinal targets will also be pursued.